Abstract
Emergent angioplasty, thrombolytic therapy, β-blockers, and even aspirin are widely believed to reduce infarct size and decrease mortality in patients who have acute myocardial infarctions (AMIs). Although these treatments are readily available, many patients are excluded from thrombolytic therapy because of a delay in seeking treatment. To be effective, treatment needs to begin early on following the onset of symptoms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
